A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharides
- PMID: 19194938
- DOI: 10.1002/btpr.36
A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of ganoderic acid and Ganoderma polysaccharides
Abstract
A novel three-stage light irradiation strategy in the submerged fermentation of medicinal mushroom Ganoderma lucidum for the efficient production of bioactive metabolites ganoderic acid (GA) and Ganoderma polysaccharides was developed. Significance of light quality, i.e., blue light (390-500 nm, lambda(max) = 470 nm), red light (560-700 nm, lambda(max) = 625 nm), and white light (400-740 nm, lambda(max) = 550 nm), was studied at first. Interestingly, there was a gradual decrease trend of GA content after the culture of day 2 when the maximal GA content was obtained, while GA content decreased slowly under white light irradiation after day 6. The dark environment was favorable to the specific GA biosynthesis (i.e., GA content) before day 6, and after that the optimum was white light irradiation. A relatively lower irradiation density of white light (i.e., 0.94 and 2.82 W/m(2)) was beneficial for the specific GA biosynthesis before day 6, while GA content was higher under higher irradiation density of white light (i.e., 4.70 and 9.40 W/m(2)) at the later-stage of cultivation. 4.70 W/m(2) white light irradiation culture was the best from the viewpoint of GA accumulation. Therefore, a two-stage light irradiation strategy by combing the first 2 days dark culture with the following 4.70 W/m(2) white light irradiation culture was developed. The highest GA production in the two-stage culture was 276.0 +/- 12.5 mg/L, which was increased by 19% compared to 4.70 W/m(2) white light irradiation culture (i.e., 232.4 +/- 15.8 mg/L) and by 178% compared to the dark culture (i.e., 99.4 +/- 1.0 mg/L). Although there still existed a gradual decrease trend of GA content after day 2 when the maximal GA content was obtained in the two-stage culture. Following three-stage light irradiation strategy was further demonstrated in order to turn around the sharp decrease of GA content after day 2. The first-stage was the 2-day dark culture; the second-stage was the following six-day 0.94 W/m(2) white light irradiation culture, and the third-stage was 4.70 W/m(2) white light irradiation culture until the end of fermentation. During the three-stage culture of G. lucidum, the gradual decrease trend of GA content after day 2 was turned around, which suggested that 0.94 W/m(2) white light irradiation was beneficial for the metabolic flux towards the GA biosynthesis. The maximal GA content of 3.1 +/- 0.1 mg/100 mg DW was obtained, which was higher by 41% compared to the two-stage culture. The maximal GA production (i.e., 466.3 +/- 24.1 mg/L) and productivity (i.e., 38.9 mg/L per day) in the three-stage culture were 69 and 101% higher than those obtained in the two-stage culture. This is the first report investigating the significance of light irradiation on the medicinal mushroom submerged fermentation. Such work is very helpful to other mushroom fermentations for useful metabolite production.
Similar articles
-
Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum.Biotechnol Prog. 2002 Jan-Feb;18(1):51-4. doi: 10.1021/bp010136g. Biotechnol Prog. 2002. PMID: 11822899
-
Performance analyses of a pH-shift and DOT-shift integrated fed-batch fermentation process for the production of ganoderic acid and Ganoderma polysaccharides by medicinal mushroom Ganoderma lucidum.Bioresour Technol. 2009 Mar;100(5):1852-9. doi: 10.1016/j.biortech.2008.10.005. Epub 2008 Nov 17. Bioresour Technol. 2009. PMID: 19010665
-
Scale-up of a liquid static culture process for hyperproduction of ganoderic acid by the medicinal mushroom Ganoderma lucidum.Biotechnol Prog. 2003 Nov-Dec;19(6):1842-6. doi: 10.1021/bp0341592. Biotechnol Prog. 2003. PMID: 14656165
-
Biotechnological production and application of ganoderic acids.Appl Microbiol Biotechnol. 2010 Jun;87(2):457-66. doi: 10.1007/s00253-010-2576-5. Epub 2010 May 2. Appl Microbiol Biotechnol. 2010. PMID: 20437236 Review.
-
Ganoderma lucidum and its pharmaceutically active compounds.Biotechnol Annu Rev. 2007;13:265-301. doi: 10.1016/S1387-2656(07)13010-6. Biotechnol Annu Rev. 2007. PMID: 17875480 Review.
Cited by
-
Molecular cloning, characterization, and function analysis of a mevalonate pyrophosphate decarboxylase gene from Ganoderma lucidum.Mol Biol Rep. 2012 May;39(5):6149-59. doi: 10.1007/s11033-011-1431-9. Epub 2011 Dec 28. Mol Biol Rep. 2012. PMID: 22203490
-
Enhanced production of polysaccharides and triterpenoids in Ganoderma lucidum fruit bodies on induction with signal transduction during the fruiting stage.PLoS One. 2018 Apr 25;13(4):e0196287. doi: 10.1371/journal.pone.0196287. eCollection 2018. PLoS One. 2018. PMID: 29694432 Free PMC article.
-
Whole-Genome Sequencing and Transcriptome Analysis of Ganoderma lucidum Strain Yw-1-5 Provides New Insights into the Enhanced Effect of Tween80 on Exopolysaccharide Production.J Fungi (Basel). 2022 Oct 14;8(10):1081. doi: 10.3390/jof8101081. J Fungi (Basel). 2022. PMID: 36294646 Free PMC article.
-
Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum.Chin Med. 2024 Mar 22;19(1):51. doi: 10.1186/s13020-024-00922-0. Chin Med. 2024. PMID: 38519991 Free PMC article. Review.
-
Deep insight into the Ganoderma lucidum by comprehensive analysis of its transcriptome.PLoS One. 2012;7(8):e44031. doi: 10.1371/journal.pone.0044031. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources